Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0001209191-22-045207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-10 | 2022-08-08 | ORMP | Sank Leonard | Dir | F - Tax | $8.77 | -9,304 | 28.7K | -24% | -$81.6K |
| D | 2022-08-10 | 2022-08-08 | ORMP | Sank Leonard | Dir | M - OptEx | $4.08 | +20.0K | 38.0K | +111% | +$81.6K |
| D | 2022-08-10 | 2022-08-08 | ORMP | Sank Leonard | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-08 | F | D | 9,304 | $8.77 | 28,696 | D | — | — | (F1) Represents a cashless exercise of outstanding stock options to purchase 20,000 shares of common stock. The reporting person received 10,696 shares of common stock and surrendered 9,304 shares of common stock underlying the stock option in payment of the exercise price. |
| 2 | Common | Common Stock | 2022-08-08 | M | A | 20,000 | $4.08 | 38,000 | D | — | — | |
| 3 | Derivative | Stock Option | 2022-08-08 | M | D | 20,000 | $0.00 | 0 | D | $4.08 · — to 2022-08-08 | 20,000 Common Stock | (F2) The options vested as follows: 10,000 vested on each of January 1, 2013 and 2014. |